WeedMD Sees CFO Nichola Thompson Resign

Today, WeedMD Inc (TSXV: WMD) officially marked the end of an era with the announcement of the departure of chief financial officer Nichola Thompson, who will be leaving the company effective April 30, 2020. Taking her place will be that of Lincoln Greenidge, who comes to the company from that of LSC Lithium Corp.

The departure of Thompson is significant, in that she was one of the last executives that remained from WeedMD prior to the merger with Starseed Medicinals, which every day looks more like that of a reverse takeover transaction than that of a merger of equals.

While the company still officially lists Derek Pedro from the original WeedMD as being the Chief Cannabis Officer of the firm, strong rumours have circulated that he has largely departed the company as well. Outside of this, senior leadership appears to have all been but replaced following the merger.

Lincoln Greenidge’s most recent experience comes as being the CEO of LSC Lithium Corp, where he performed a strategic review that culminated in the sale of the company for $110 million. Greenidge acquired his Bachelor of Commerce in Accounting with Honours from the University of Ottawa.

We are pleased to welcome Lincoln to our leadership team. His experience will be essential to leading our financial organization, supporting the integration of WeedMD’s recent acquisition of Starseed and the continued commercialization of our cultivation platform. I also want to thank Nichola Thompson for her service as our CFO. During the past two years, she has made a number of lasting contributions to our organization’s success. We wish her the best in her future endeavours and thank her for assisting us through this transition.

Angelo Tsebelis, CEO of WeedMD

WeedMD last traded at $0.36 on the TSX Venture.

Information for this analysis was found via Sedar, and WeedMD Inc. The author has no securities related to this organization. WeedMD Inc was previously a client of CanaCom Group, the parent company of The Deep Dive. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.